Suppr超能文献

坏死在少突胶质细胞瘤分级中的意义:一项对新诊断的高级别胶质瘤的临床病理和遗传学研究

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

作者信息

Miller C Ryan, Dunham Christopher P, Scheithauer Bernd W, Perry Arie

机构信息

Division of Neuropathology, Washington University School of Medicine, St Louis, MO 63110, USA.

出版信息

J Clin Oncol. 2006 Dec 1;24(34):5419-26. doi: 10.1200/JCO.2006.08.1497.

Abstract

PURPOSE

High-grade gliomas (HGGs; WHO grades 3-4) are highly diverse, with survival times ranging from months to years. WHO 2000 grading criteria for high-grade oligodendroglial neoplasms [anaplastic oligoastrocytoma (AOA) and anaplastic oligodendroglioma (AO)] remain subjective, and the existence of grade 4 variants is controversial.

PATIENTS AND METHODS

Overall survival (OS) of 1,093 adult patients with a cerebral HGG newly diagnosed between 1990 and 2005 was analyzed by univariate and multivariate models for significance of the following factors: patient age, surgery type, year of diagnosis, endothelial proliferation, necrosis, oligodendroglial histology, treatment center, and chromosome 1p, 19q, 7p (EGFR), and 10q (PTEN) abnormalities by fluorescence in situ hybridization (FISH).

RESULTS

Necrosis was a statistically significant predictor of poor OS on univariate and multivariate analyses in AOA but not in AO. Median OS for patients with necrotic AOA (22.8 months) was significantly worse than for patients with non-necrotic AOA (86.9 months; P < .0001) but was better than conventional glioblastomas (9.8 months; P < .0001). In addition to patient age, the following were significant independent prognostic factors (P .001): grade and surgery type for the entire HGG cohort; modified grade for AOA (3 v 4); and modified grade, 1p/19q codeletion status, and oligodendroglial histology for the 586 HGGs analyzed by FISH.

CONCLUSION

Stratification of AOA, but not of pure AO, into grades 3 and 4 on the basis of necrosis is prognostically justified and is more powerful than the current approach. Both routine histology and genetic testing provide independent, prognostically useful information.

摘要

目的

高级别胶质瘤(HGG;世界卫生组织3 - 4级)具有高度多样性,生存时间从数月到数年不等。世界卫生组织2000年关于高级别少突胶质细胞瘤[间变性少突星形细胞瘤(AOA)和间变性少突胶质细胞瘤(AO)]的分级标准仍然主观,且4级变体的存在存在争议。

患者与方法

对1990年至2005年间新诊断的1093例成人脑HGG患者的总生存期(OS)进行单因素和多因素模型分析,以确定以下因素的显著性:患者年龄、手术类型、诊断年份、内皮细胞增殖、坏死、少突胶质细胞组织学、治疗中心以及通过荧光原位杂交(FISH)检测的1号染色体短臂(1p)、19号染色体长臂(19q)、7号染色体短臂(EGFR)和10号染色体长臂(PTEN)异常情况。

结果

在单因素和多因素分析中,坏死是AOA患者OS较差的统计学显著预测因素,但在AO患者中并非如此。坏死性AOA患者的中位OS(22.8个月)显著差于非坏死性AOA患者(86.9个月;P <.0001),但优于传统胶质母细胞瘤(9.8个月;P <.0001)。除患者年龄外,以下因素为显著的独立预后因素(P <.001):整个HGG队列的分级和手术类型;AOA的改良分级(3级对4级);以及通过FISH分析的586例HGG的改良分级、1p/19q共缺失状态和少突胶质细胞组织学。

结论

基于坏死将AOA(而非纯AO)分为3级和4级在预后方面是合理的,且比当前方法更有效。常规组织学和基因检测均提供独立的、对预后有用的信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验